Astex Pharmaceuticals, Inc.
299 articles with Astex Pharmaceuticals, Inc.
-
Astex Pharmaceuticals to Present at Lazard Healthcare Conference
11/7/2012
-
Astex Pharmaceuticals to Present at EORTC-National Cancer Institute-American Association for Cancer Research
10/31/2012
-
Astex Pharmaceuticals Reports 2012 Third Quarter Financial Results
10/31/2012
-
Astex Pharmaceuticals. Cancer Research Technology and Newcastle University Sign Strategic Drug Discovery Alliance
10/29/2012
-
Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer
10/24/2012
-
Astex Pharmaceuticals to Announce 2012 Third Quarter Financial Results on October 30, 2012
10/23/2012
-
Astex Pharmaceuticals Scientists Publish the Discovery of Novel Allosteric Modulators for the Key Therapeutic Targets HCV NS3 and PKM2 in Nature Journals
10/15/2012
-
Astex Pharmaceuticals Announces the Appointment of President Harren Jhoti, PhD to the BioIndustry Association Board of Directors
10/10/2012
-
Astex Pharmaceuticals Earns $5 Million for First Commercial Sale of DACOGENĀ® in the European Union
10/9/2012
-
Astex Pharmaceuticals to Present at Biotechnology Industry Organization (BIO) Investor Forum
10/2/2012
-
Astex Pharmaceuticals Says EU OKs Marketing for its Leukemia Drug
9/28/2012
-
Astex Pharmaceuticals Ends Development of Lung Cancer Drug
9/24/2012
-
Astex Pharmaceuticals to Participate on Oncology Panels at Upcoming Investor Conferences
9/18/2012
-
Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients
9/10/2012
-
Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration
9/6/2012
-
Astex Pharmaceuticals to Participate on Epigenetics Panel at Rodman & Renshaw Conference
9/4/2012
-
Astex Pharmaceuticals to Present at September Investor Conferences
8/30/2012
-
Astex Pharmaceuticals Climbs on Expected European Approval
8/23/2012
-
Astex Pharmaceuticals President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
8/20/2012
-
Astex Pharmaceuticals Reports 2012 Second Quarter Financial Results
7/31/2012